Treatment of Seborrheic Dermatitis
The recommended first-line treatment for seborrheic dermatitis includes topical antifungal agents such as ketoconazole 2% cream applied twice daily for four weeks, along with mild corticosteroids for inflammation control. This approach targets both the underlying Malassezia fungal colonization and inflammatory response that characterize this condition 1, 2.
Pathophysiology and Clinical Presentation
Seborrheic dermatitis is a common chronic inflammatory skin disorder affecting areas rich in sebaceous glands, particularly:
- Scalp (dandruff)
- Face (especially nasolabial folds, eyebrows, glabella)
- Ears (including ear canals)
- Central chest
- Body folds
The condition is associated with:
- Malassezia yeast overgrowth
- Sebaceous gland activity
- Abnormal immune response
- Possible genetic predisposition
Clinical features include:
- Erythematous patches/plaques
- Greasy or yellowish scaling
- Mild to moderate pruritus
- In infants: "cradle cap" with yellowish, scaly patches
Treatment Algorithm
First-line Treatment:
Topical Antifungals:
Topical Anti-inflammatories:
Scalp Treatment:
Maintenance Therapy:
- After initial control, reduce antifungal application to 1-2 times weekly
- Use gentle, non-soap cleansers
- Continue medicated shampoos 1-2 times weekly for scalp involvement
For Resistant Cases:
Topical Calcineurin Inhibitors:
Systemic Treatment:
Phototherapy:
Special Considerations
Facial Involvement:
- Avoid potent corticosteroids
- Limit mild corticosteroids to short courses (1-2 weeks)
- Consider topical calcineurin inhibitors for steroid-sparing effect
Infantile Seborrheic Dermatitis:
- Usually self-limiting
- Gentle baby shampoos with emollients
- Medical device shampoos containing piroctone olamine, bisabolol 2
- Avoid prolonged corticosteroid use
Adjunctive Measures:
- Gentle skin care with pH-neutral cleansers
- Avoid irritants, alcohol-based products
- Non-pharmacological products with zinc, piroctone olamine may help prevent recurrences 8
Monitoring and Follow-up
- Evaluate response after 2-4 weeks of treatment
- If no improvement, reconsider diagnosis (possible psoriasis, eczema, tinea, or other dermatoses)
- For recurrent cases, maintenance therapy with weekly antifungal applications may be necessary
Common Pitfalls to Avoid
- Overuse of corticosteroids: Can lead to skin atrophy, telangiectasia, and tachyphylaxis
- Inadequate treatment duration: Full 4-week course of antifungals often needed for complete resolution
- Misdiagnosis: Seborrheic dermatitis can be confused with psoriasis, eczema, or tinea faciei
- Neglecting maintenance therapy: Seborrheic dermatitis is chronic and often recurs without ongoing management
The combination of antifungal and anti-inflammatory treatments addresses both the underlying cause and symptoms, providing effective control of seborrheic dermatitis while minimizing side effects from prolonged corticosteroid use.